Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16970952rdf:typepubmed:Citationlld:pubmed
pubmed-article:16970952lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:16970952lifeskim:mentionsumls-concept:C0030274lld:lifeskim
pubmed-article:16970952lifeskim:mentionsumls-concept:C0005330lld:lifeskim
pubmed-article:16970952lifeskim:mentionsumls-concept:C0021655lld:lifeskim
pubmed-article:16970952lifeskim:mentionsumls-concept:C0011847lld:lifeskim
pubmed-article:16970952lifeskim:mentionsumls-concept:C0542341lld:lifeskim
pubmed-article:16970952lifeskim:mentionsumls-concept:C0023983lld:lifeskim
pubmed-article:16970952pubmed:issue1lld:pubmed
pubmed-article:16970952pubmed:dateCreated2007-10-23lld:pubmed
pubmed-article:16970952pubmed:abstractTextDevelopment of insulin resistance (IR) and the progressive failure of the pancreatic beta-cell function (BCF) may be important in the pathogenesis of type 2 diabetes. Influence of peroxisome proliferator-activated receptors ligand bezafibrate on BCF and IR in patients with diabetes is unknown. The present study was aimed to investigate the long-term effect of bezafibrate on these parameters in diabetic patients enrolled in the Bezafibrate Infarction Prevention (BIP) Study.lld:pubmed
pubmed-article:16970952pubmed:languageenglld:pubmed
pubmed-article:16970952pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16970952pubmed:citationSubsetIMlld:pubmed
pubmed-article:16970952pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16970952pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16970952pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16970952pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16970952pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16970952pubmed:statusMEDLINElld:pubmed
pubmed-article:16970952pubmed:monthSeplld:pubmed
pubmed-article:16970952pubmed:issn1879-1484lld:pubmed
pubmed-article:16970952pubmed:authorpubmed-author:TanneDavidDlld:pubmed
pubmed-article:16970952pubmed:authorpubmed-author:BoykoValentin...lld:pubmed
pubmed-article:16970952pubmed:authorpubmed-author:AdlerYehudaYlld:pubmed
pubmed-article:16970952pubmed:authorpubmed-author:BeharSolomonSlld:pubmed
pubmed-article:16970952pubmed:authorpubmed-author:MotroMichaelMlld:pubmed
pubmed-article:16970952pubmed:authorpubmed-author:TenenbaumAlex...lld:pubmed
pubmed-article:16970952pubmed:authorpubmed-author:FismanEnrique...lld:pubmed
pubmed-article:16970952pubmed:authorpubmed-author:MatasZiporaZlld:pubmed
pubmed-article:16970952pubmed:authorpubmed-author:Schwammenthal...lld:pubmed
pubmed-article:16970952pubmed:authorpubmed-author:TenenbaumHele...lld:pubmed
pubmed-article:16970952pubmed:authorpubmed-author:LapidotMordec...lld:pubmed
pubmed-article:16970952pubmed:authorpubmed-author:FeinbergMicha...lld:pubmed
pubmed-article:16970952pubmed:issnTypeElectroniclld:pubmed
pubmed-article:16970952pubmed:volume194lld:pubmed
pubmed-article:16970952pubmed:ownerNLMlld:pubmed
pubmed-article:16970952pubmed:authorsCompleteYlld:pubmed
pubmed-article:16970952pubmed:pagination265-71lld:pubmed
pubmed-article:16970952pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:16970952pubmed:meshHeadingpubmed-meshheading:16970952...lld:pubmed
pubmed-article:16970952pubmed:meshHeadingpubmed-meshheading:16970952...lld:pubmed
pubmed-article:16970952pubmed:meshHeadingpubmed-meshheading:16970952...lld:pubmed
pubmed-article:16970952pubmed:meshHeadingpubmed-meshheading:16970952...lld:pubmed
pubmed-article:16970952pubmed:meshHeadingpubmed-meshheading:16970952...lld:pubmed
pubmed-article:16970952pubmed:meshHeadingpubmed-meshheading:16970952...lld:pubmed
pubmed-article:16970952pubmed:meshHeadingpubmed-meshheading:16970952...lld:pubmed
pubmed-article:16970952pubmed:meshHeadingpubmed-meshheading:16970952...lld:pubmed
pubmed-article:16970952pubmed:meshHeadingpubmed-meshheading:16970952...lld:pubmed
pubmed-article:16970952pubmed:meshHeadingpubmed-meshheading:16970952...lld:pubmed
pubmed-article:16970952pubmed:meshHeadingpubmed-meshheading:16970952...lld:pubmed
pubmed-article:16970952pubmed:meshHeadingpubmed-meshheading:16970952...lld:pubmed
pubmed-article:16970952pubmed:meshHeadingpubmed-meshheading:16970952...lld:pubmed
pubmed-article:16970952pubmed:meshHeadingpubmed-meshheading:16970952...lld:pubmed
pubmed-article:16970952pubmed:meshHeadingpubmed-meshheading:16970952...lld:pubmed
pubmed-article:16970952pubmed:meshHeadingpubmed-meshheading:16970952...lld:pubmed
pubmed-article:16970952pubmed:meshHeadingpubmed-meshheading:16970952...lld:pubmed
pubmed-article:16970952pubmed:year2007lld:pubmed
pubmed-article:16970952pubmed:articleTitleLong-term effect of bezafibrate on pancreatic beta-cell function and insulin resistance in patients with diabetes.lld:pubmed
pubmed-article:16970952pubmed:affiliationEndocrinology and Diabetes Unit, Dan-Petah-Tikva District, Clalit Health Services, Israel.lld:pubmed
pubmed-article:16970952pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16970952pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16970952lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16970952lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16970952lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16970952lld:pubmed